Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias

Dementia and Geriatric Cognitive Disorders

Volumn 22, Issue 5-6, 2006, Pages 413-420

  Hsiung, Ging Yuek R ^a   Donald, Alan ^a   Grand, Jacob ^a   Black, Sandra E ^b   Bouchard, Remi W ^c   Gauthier, Serge G ^d   Loy English, Inge ^e   Hogan, David B ^f   Kertesz, Andrew ^g   Rockwood, Kenneth ^h   Feldman, Howard H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; ApoE; Cognitively impaired not demented; Dementia; Longitudinal cohort; Mild cognitive impairment

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CANADA; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FOLLOW UP; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYNDROME;

EID: 33750916734     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095751     Document Type: Article

References (30)

1. Petersen RC, Smith GE, Waring SC, et al: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
2. Petersen RC, Doody R, Kurz A, et al: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
3. Crook TH, Bartus RT, Ferris SH, et al: Age-associated memory impairment: Proposed diagnostic criteria and measure of clinical change - Report of a National Institute of Mental Health Work Group. Dev Neuropsychol 1986;2:261-276.
4. Blackford R, La Rue A: Criteria for diagnosing age-associated memory impairment: proposed improvements from the field. Dev Neuropsychol 1989;5:295-306.
5. Crook TH, Larrabee GJ, Youngjohn JR: Diagnosis and assessment of age-associated memory impairment. Clin Neuropharmacol 1990;13(suppl 3):S81-S91.
6. Levy R: Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in Collaboration with the World Health Organization. Int Psychogeriatr 1994;6:63-68.
7. Graham JE, Rockwood K, Beattie BL, et al: Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;49:1793-1796.
8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. Washington, DC, American Psychiatric Association, 1987.
9. CSHA: Canadian study of health and aging: study methods and prevalence of dementia. CMAJ 1994;150:899-913.
10. Tuokko H, Frerichs R, Graham J, et al: Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 2003;60:577-582.
11. Solfrizzi V, Panza F, Colacicco AM, et al: Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004;63:1882-1891.
12. Feldman H, Levy AR, Hsiung GY, et al: A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology 2003;22:265-274.
13. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
14. Rockwood K, Davis H, MacKnight C, et al: The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. Can J Neurol Sci 2003;30:237-243.
15. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
16. Lund and Manchester Groups: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
17. McKeith IG, Galasko D, Kosaka K, et al., Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
18. Folstein MF, Robins LN, Helzer JE: The Mini-Mental State Examination. Arch Gen Psychiatry 1983;40:812.
19. Crockett D, Tuokko H, Koch W, et al: The assessment of everyday functioning using the Present Runctioning Questionnaire and the Functional Rating Scale in elderly samples. Clin Gerontol 1989;8:3-25.
20. Tuokko H, Crockett D, Beattie BL, et al: The use of rating scales to assess psychosocial functioning in demented patients. J Clin Exp Neuropsychol 1985;7:615.
21. Parmelee PA, Thuras PD, Katz IR, et al: Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc 1995;43:130-137.
22. Linn BS, Linn MW, Gurel L: Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622-626.
23. Gelinas I, Gauthier L, McIntyre M, et al: Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther 1999;53:471-481.
24. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
25. Ganguli M, Dodge HH, Shen C, et al: Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004;63:115-121.
26. Unverzagt FW, Gao S, Baiyewu O, et al: Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 2001;57:1655-1662.
27. Larrieu S, Letenneur L, Orgogozo JM, et al: Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002;59:1594-1599.
28. Fisk JD, Merry HR, Rockwood K: Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 2003;61:1179-1184.
29. Hogan DB, Ebly EM: Predicting who will develop dementia in a cohort of Canadian seniors. Can J Neurol Sci 2000;27:18-24.
30. Hsiung GY, Sadovnick AD, Feldman H: Apolipoprotein E e4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ 2004;171:863-867.